A Study to Evaluate Different Dose Levels of Ad26.COV2.S in Healthy Adolescents From 12 to 17 Years Inclusive

NCT05007080 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

304

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronavirus Disease-2019 (COVID-19) Prevention

Interventions

BIOLOGICAL: Ad26.COV2.S

Sponsor

Janssen Vaccines & Prevention B.V.